ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2291

Correlation and Concordance Between the Oxford Grading Scale, Ocular Staining Score, and van BijsterveldScore in the diagnosis of Sjögren’s Disease

Alejandro Gómez Gómez1, Eric Kirkegaard-Biosca2, Sergio H. Martínez Mateu3, Iago Alvarez Saez4, Natalia Boix- Martí5, Antonio Julià1, Jose Luis Andreu6 and Sara Marsal1, 1Vall d'Hebron Hospital Research Institute, Rheumatology Research Group, Barcelona, Spain, 2Hospital Univetsitari Vall d'Hebron, Ophthalmology Department, Barcelona, Spain, 3IMIDomics, Barcelona, Spain, 4Hospital Univetsitari Vall d'Hebron, Maxilofacial Surgery Department, Barcelona, Spain, 5Hospital Univetsitari Vall d'Hebron, Rheumatology Department, Barcelona, Spain, 6Hospital Universitario Puerta de Hierro, Majadahonda, Spain

Meeting: ACR Convergence 2025

Keywords: Eye Disorders, Sjögren's syndrome

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, October 28, 2025

Title: (2290–2304) Sjögren’s Disease – Basic & Clinical Science Poster III: Treatment and Trial Outcome Measures

Session Type: Poster Session C

Session Time: 10:30AM-12:30PM

Background/Purpose: Sjögren’s Disease (SjD) is a systemic autoimmune disorder marked by mucosal dryness and ocular surface damage. For diagnosis, the ACR-EULAR 2016 criteria require the Ocular Staining Score (OSS) or the van Bijsterveld score (vBs), both rarely used in routine care. The Oxford Grading Scale (OGS), a simpler and widely applied tool, may offer a more accessible alternative. The objective of this study is to assess the correlation and diagnostic agreement of OGS with OSS and vBs in patients fulfilling the ACR-EULAR 2016 criteria for SjD, aiming to support its use as a practical screening method.

Methods: We conducted a cross-sectional study of 20 patients from the SSAD project at a single center (June–December 2024), all meeting ACR-EULAR 2016 criteria for SjD. Each underwent ocular surface staining assessments using the OSS, vBs, and OGS on the same day, following standardized protocols (Figures A-C).OSS evaluates corneal and conjunctival staining (0–12) with fluorescein and lissamine green; vBs scores three conjunctival zones (0–9) using the same dyes; OGS assesses corneal epithelial damage (0–5) via fluorescein staining. Positive thresholds were OSS ≥5 or vBs ≥4 per ACR-EULAR criteria. OGS thresholds were explored to determine optimal concordance with OSS and vBs.We analyzed correlations using Spearman’s rho for continuous scores and assessed agreement through percentage concordance and Cohen’s kappa for binary classifications. OGS positivity was determined across various thresholds, selecting the one maximizing Cohen’s kappa for further analysis. OSS and vBs served as reference standards to calculate OGS’s positive and negative predictive values at different thresholds.

Results: A total of 20 patients (mean age 57 years, 16 women [80%]) who met the classification criteria for SjD, regardless of their OSS or vBS results, were included.A Near-perfect agreement between standard scoring systems (OSS and vBs) was observed (rho = 0.94, p < 0.001 for both eyes).A Moderate-to-good agreement was observed for positive/negative classification based on ACR-EULAR thresholds (OSS ≥5, vBS ≥4), with 85% concordance (kappa = 0.67). Discrepancies were partially atributable to the treshold differences; for instance, some cases had a vBS of 4 (classified as positive) but an OSS of 3 or 4 (negative).OGS showed Moderate correlations with both OSS and vBs, ranging from rho=0.44 to rho=0.6, slightly higher for OSS than for vBS.An OGS threshold of ≥1 in at least one eye yielded the highest agreement with OSS and vBS (kappa: 0.5 for OSS, 0.6 for vBS), with excellent negative predictive values (NPV: 1.0 for OSS, 0.9 for vBS) but modest positive predictive values (PPV: 0.5 for OSS, 0.7 for vBS).The PPV-maximizing cutoffs were OGS ≥3 for OSS (PPV = 1) and OGS ≥2 for vBS (PPV = 0.70). These are conservative thresholds with only 1 and 3 positive cases, respectively.Notably, all patients with a positive vBS were also OSS-positive, suggesting OSS may be the more conservative assessment.

Conclusion: OGS moderately correlates with OSS and vBs and shows excellent rule-out capability when the score is 0. Given its simplicity and high NPV, OGS could serve as a practical screening tool for ocular damage in SjD, especially in settings lacking access to OSS or vBs.

Supporting image 1Figures A–C: Simultaneous ocular surface staining in a patient with Sjögren’s disease (SjD).

A: Fluorescein staining of the ocular surface.

B–C: Lissamine green staining of the cornea (B) and conjunctiva (C).


Disclosures: A. Gómez Gómez: None; E. Kirkegaard-Biosca: None; S. Martínez Mateu: None; I. Alvarez Saez: None; N. Boix- Martí: None; A. Julià: None; J. Andreu: None; S. Marsal: AbbVie/Abbott, 5, Bristol-Myers Squibb(BMS), 5, Eli Lilly, 1, 5, IMIDomics, 4, 8, Janssen, 5, Merck/MSD, 5, Novartis, 5, Roche, 5, UCB, 5.

To cite this abstract in AMA style:

Gómez Gómez A, Kirkegaard-Biosca E, Martínez Mateu S, Alvarez Saez I, Boix- Martí N, Julià A, Andreu J, Marsal S. Correlation and Concordance Between the Oxford Grading Scale, Ocular Staining Score, and van BijsterveldScore in the diagnosis of Sjögren’s Disease [abstract]. Arthritis Rheumatol. 2025; 77 (suppl 9). https://acrabstracts.org/abstract/correlation-and-concordance-between-the-oxford-grading-scale-ocular-staining-score-and-van-bijsterveldscore-in-the-diagnosis-of-sjogrens-disease/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2025

ACR Meeting Abstracts - https://acrabstracts.org/abstract/correlation-and-concordance-between-the-oxford-grading-scale-ocular-staining-score-and-van-bijsterveldscore-in-the-diagnosis-of-sjogrens-disease/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology